logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
07/11/2025
The Governor of the Bank of Canada's opening remarks at the Senate committee were completely consistent with his remarks in the House of Commons on Wednesday.
Latest
2 m ago
Nord and Nord: Negotiations under the framework of the White House agreement and the "Lowering Inflation Act" are independent of each other.
2 m ago
The US government, Eli Lilly and Novo Nordisk announced an agreement to lower the price of GLP-1 weight loss drugs. Both companies will price it at $245 per month.
3 m ago
Rei Lai Company: According to the agreement, the cost for self-paying patients to purchase the lowest dose version of Zepbound is $299, and the cost for higher dose versions is $449 per month.
3 m ago
Rey Pharmaceutical Company: If its experimental drug Ofgalapril tablet is approved, it will implement a low-price strategy.
3 m ago
Lilly Corporation: Will be adding the diabetes drugs EMGALITY, TRULICITY, and MOUNJARO to its website that directly targets consumers, priced 50%-60% lower than the standard price.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.